Key result
Type 2 diabetes combined with high blood pressure was associated with significantly higher levels of D-dimer and plasminogen activator inhibitor-1 compared to controls, indicating hypercoagulability.
Cross-Sectional
Answers are grounded in this paper and cite their sources.
Patients with type 2 diabetes and high blood pressure demonstrate hypercoagulability and hypofibrinolysis despite normal markers of endothelial injury.
This study aimed to investigate whether endothelial cells are damaged and to evaluate fibrinolytic system function in patients with type 2 diabetes. For this proposal, plasma levels of von Willebrand factor (an endothelial marker of injury), homocysteine (an inductor of endothelial injury), D-dimer (a marker of coagulation cascade activation) and plasminogen activator inhibitor-1 (a fibrinolysis marker) were measured in individuals with both type 2 diabetes and high blood pressure, with type 2 diabetes, with high blood pressure and in healthy control individuals. No significant differences among groups were observed for von Willebrand factor and homocysteine plasma levels. The type 2 diabetes and high blood pressure group presented a significant difference to the other groups for D-dimer and also presented high values for plasminogen activator inhibitor-1. The high blood pressure group and type 2 diabetes group presented separately higher values of plasminogen activator inhibitor-1 compared with the control group. High levels of D-dimer and plasminogen activator inhibitor-1 in patients with type 2 diabetes and high blood pressure with normoalbuminuria therefore indicate a state of hypercoagulability and hypofibrinolysis, despite no evident microvascular injury supported by normal levels of von Willebrand factor and homocysteine.
No takes yet. Share an insight, caveat, or question.
Soares et al. (2007) conducted a cross-sectional in Type 2 diabetes and high blood pressure. Type 2 diabetes and high blood pressure vs. Healthy control individuals was evaluated on Plasma levels of von Willebrand factor, homocysteine, D-dimer, and plasminogen activator inhibitor-1. Type 2 diabetes combined with high blood pressure was associated with significantly higher levels of D-dimer and plasminogen activator inhibitor-1 compared to controls, indicating hypercoagulability.
Synapse has enriched 10 related papers. Consider them for comparative context: